Metabolomics of Bladder Cancer An Emerging Application
-
- Taschenbuch
- eBook ausgewählt
-
Form:Einzelkauf Download
-
Sprache:Englisch
163,99 €
inkl. gesetzl. MwSt.Beschreibung
Produktdetails
Format
ePUB 3
Kopierschutz
Nein
Family Sharing
Nein
Text-to-Speech
Ja
Erscheinungsdatum
09.09.2024
Herausgeber
Vishwajeet Singh + weitereVerlag
Elsevier Science & Techn.Seitenzahl
200 (Printausgabe)
Dateigröße
15741 KB
Sprache
Englisch
EAN
9780443238826
Metabolomics of Bladder Cancer: An Emerging Application offers insights into the latest research methodologies and potential therapeutic applications. The book examines how applied research on the discovery of metabolomic biomarkers with prognostic and predictive value is needed to stratify patients into different risk groups, minimizing overtreatment and the risk of drug resistance development. In eight chapters, the book gives an in-depth analysis of recent findings in both fundamental and applied research, with a focus on the metabolomics approach and its potential for identifying major metabolic pathways that characterize various diseases and physiological states.It intuitively leads from the discovery of biomarkers for bladder cancer, to the metabolisms of glutamine and fatty acids and finalizes with a chapter on the metabolic effect of cancer therapy. Overall, this book is a comprehensive and insightful resource for researchers, clinicians, and academic professionals interested in the latest developments in bladder cancer research.
- Gives an in-depth analysis of the most recent findings in both fundamental and applied research on bladder cancer
- Focuses on metabolomics and how this type of research strategy identifies biomarkers to understand the disease and identify targetable therapeutic molecules
- Provides insight into the technological advancements in metabolomic analysis for bladder cancer
- Gives an in-depth analysis of the most recent findings in both fundamental and applied research on bladder cancer
- Focuses on metabolomics and how this type of research strategy identifies biomarkers to understand the disease and identify targetable therapeutic molecules
- Provides insight into the technological advancements in metabolomic analysis for bladder cancer
Noch keine Bewertungen vorhanden
Verfassen Sie die erste Bewertung zu diesem Artikel
Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.
Kurze Frage zu unserer Seite
Vielen Dank für Ihr Feedback
Wir nutzen Ihr Feedback, um unsere Produktseiten zu verbessern. Bitte haben Sie Verständnis, dass wir Ihnen keine Rückmeldung geben können. Falls Sie Kontakt mit uns aufnehmen möchten, können Sie sich aber gerne an unseren Kund*innenservice wenden.
zum Kundenservice